<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20201214</date><key>pmc.key</key><document><id>2022678</id><infon key="license">CC0</infon><passage><infon key="article-id_doi">10.1289/ehp.9906</infon><infon key="article-id_pmc">2022678</infon><infon key="article-id_pmid">17938743</infon><infon key="article-id_publisher-id">ehp0115-001503</infon><infon key="fpage">1503</infon><infon key="issue">10</infon><infon key="kwd">arsenic B12 blood arsenic metabolites DMA folate homocysteine maternal MMA newborn</infon><infon key="license">Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright. </infon><infon key="lpage">1509</infon><infon key="name_0">surname:Hall;given-names:Marni</infon><infon key="name_1">surname:Gamble;given-names:Mary</infon><infon key="name_10">surname:Graziano;given-names:Joseph</infon><infon key="name_2">surname:Slavkovich;given-names:Vesna</infon><infon key="name_3">surname:Liu;given-names:Xinhua</infon><infon key="name_4">surname:Levy;given-names:Diane</infon><infon key="name_5">surname:Cheng;given-names:Zhongqi</infon><infon key="name_6">surname:van Geen;given-names:Alexander</infon><infon key="name_7">surname:Yunus;given-names:Mahammad</infon><infon key="name_8">surname:Rahman;given-names:Mahfuzar</infon><infon key="name_9">surname:Pilsner;given-names:J. Richard</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">115</infon><infon key="year">2007</infon><offset>0</offset><text>Determinants of Arsenic Metabolism: Blood Arsenic Metabolites, Plasma Folate, Cobalamin, and Homocysteine Concentrations in MaternalâNewborn Pairs</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>149</offset><text>Background</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>160</offset><text>In Bangladesh, tens of millions of people have been consuming waterborne arsenic for decades. The extent to which As is transported to the fetus during pregnancy has not been well characterized.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>355</offset><text>Objectives</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>366</offset><text>We therefore conducted a study of 101 pregnant women who gave birth in Matlab, Bangladesh.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>457</offset><text>Methods</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>465</offset><text>Maternal and cord blood pairs were collected and concentrations of total As were analyzed for 101 pairs, and As metabolites for 30 pairs. Maternal urinary As metabolites and plasma folate, cobalamin, and homocysteine levels in maternal cord pairs were also measured. Household tube wellâwater As concentrations exceeded the World Health Organization guideline of 10 Î¼g/L in 38% of the cases.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>860</offset><text>Results</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>868</offset><text>We observed strong associations between maternal and cord blood concentrations of total As (r = 0.93, p &lt; 0.0001). Maternal and cord blood arsenic metabolites (n = 30) were also strongly correlated: in dimethylarsinate (DMA) (r = 0.94, p &lt; 0.0001), monomethylarsonate (r = 0.80, p &lt; 0.0001), arsenite (As+3) (r = 0.80, p &lt; 0.0001), and arsenate (As+5) (r = 0.89, p &lt; 0.0001). Maternal homocysteine was a strong predictor of %DMA in maternal urine, maternal blood, and cord blood (Î² = â6.2, p &lt; 0.02; Î² = â10.9, p &lt; 0.04; and Î² = â13.7, p &lt; 0.04, respectively). Maternal folate was inversely associated with maternal blood As5+ (Î² = 0.56, p &lt; 0.05), and maternal cobalamin was inversely associated with cord blood As5+ (Î² = â1.2, p &lt; 0.01).</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1623</offset><text>Conclusions</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1635</offset><text>We conclude that exposure to all metabolites of inorganic As occurs in the prenatal period.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1727</offset><text>Exposure to arsenic-contaminated drinking water represents one of the largest public health poisonings in history, affecting tens of millions of people worldwide. Bangladesh is one of the most severely affected regions. Adverse health effects associated with chronic exposure to As-contaminated water include skin, bladder, kidney, and liver cancers, diabetes, and hypertension. Reports in the literature suggest that inorganic As (InAs) also poses increased reproductive and developmental risks in animals, though few human studies have focused on these outcomes. Relatively little is known about transplacental transfer of As. Several studies have addressed the impact of human prenatal As exposure, and have reported increases in miscarriage, stillbirths, and congenital heart disease.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2516</offset><text>The As in drinking water is typically inorganic, and can be present either as As+3 (arsenite) or As+5 (arsenate). In Bangladesh, As is primarily in the As+3 form, though there are reports of a significant +5 fraction in other parts of the Bengal Delta. The metabolism of As in humans involves a series of reactions that alternates reduction of pentavalent As species to the trivalent state with oxidative methylation steps. In humans this process results in distinct As species, including As+3, As+5, monomethylarsonous acid (MMA+3), monomethylarsonic acid (MMA+5) and dimethlyarsinic acid (DMA+5), each with unique toxicology. The trivalent As forms, which have a higher affinity for thiol groups, are more cytoxic and genotoxic than pentavalent forms. Individuals who accumulate the trivalent intermediates are thought to be at greater risk of As-induced diseases. A series of studies from Taiwan indicate that individuals who excrete relatively lower proportions of urinary DMA(+3) + (+5) are at increased risk for skin and bladder cancers and for peripheral vascular disease.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3596</offset><text>Interindividual differences in metabolism of As are thought to account for some of the observed variation in susceptibility to As-related diseases. Low body mass index and reduced methylation capacity are thought to impair As metabolism and enhance toxicity. Arsenic is methylated by S-adenosylmethionine (SAM) via one-carbon metabolism, a biochemical pathway that uses folate for recruitment of methyl groups and cobalamin (B12) as a cofactor. We previously reported a high prevalence of hyperhomocysteinemia in Bangladesh that was found to be associated with reduced As methylation. We also found that As methylation can be increased with folic acid supplementation (.)</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4268</offset><text>Early manifestations of arsenicosis, such as skin lesions, occur in adults after many years of exposure, whereas As-induced cancers and cardiovascular disease take decades to develop. Little is known about the comparable latency periods in children. Anecdotally, we have observed As-induced skin lesions in preschool-age children in Bangladesh, and have become concerned for children who are now being born to a generation of mothers who have been exposed to As for much or all of their lives. In addition, we recently reported that young children exposed to As in drinking water exhibit dose-dependent intellectual impairment. These observations strongly suggest that As exposure in utero and/or during early childhood may be contributing to As-induced health effects in children. To determine the early health effects associated with As, prenatal exposures must be better characterized. The purpose of this study was to characterize the As metabolic profiles in maternalâcord blood pairs, and to determine the extent to which maternal folate and B12 status influences maternal As metabolism. Here we report total blood As, urinary As metabolites, folate, B12, and homocysteine findings in 101 maternalâcord blood pairs derived from births in Matlab, Bangladesh, an area with a high prevalence of elevated As concentrations in tube-well water. We also describe blood As metabolites in the 30 maternalâcord pairs that had the highest total blood As.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>5724</offset><text>Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>5732</offset><text>Study participants</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5751</offset><text>This study was approved by the Institutional Review Board of the Columbia University Medical Center and the Ethical Review Committee of the International Centre for Diarrheal Disease Research-Bangladesh (ICDDR-B). Between December 2004 and April 2005, pregnant women who appeared at the main hospital in Matlab, Bangladesh, were asked to participate in the study by the attending physican. For the past 30 years, ICDDR-B has carried out a disease surveillance program in Matlab, an area that is roughly 20 km north of Araihazar. Matlab is a region that has variable concentrations of As in groundwater, and where relatively little As remediation had been carried out at the time of the study. Through the efforts of ICDDR-B, roughly half of all women in Matlab now deliver their babies in the main hospital or in one of several medical field stations in the region.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6617</offset><text>A convenience sample of 104 pregnant women participated in the study, all of whom signed written informed consent. This group is not necessarily representative of all women in the study region. The project benefited from the ICDDR-B health and demographic surveillance system (HDSS) in Matlab. HDSS records all vital events, such as births, deaths, marriages, including the date of the last menstrual period, pregnancies, and pregnancy outcomes, as well as in- and out-migration. During their pregnancies, all women were provided with daily iron (60 mg/day) and folic acid (300 Î¼g/day) supplements.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>7217</offset><text>Sample collection and storage</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7247</offset><text>Near the time of delivery, women were asked to provide written informed consent, to answer a brief questionnaire, to provide a blood and urine sample before delivery, and to allow a blood sample to be obtained from the discarded umbilical cord after the birth of the baby. The maternal and cord blood samples were typically taken within 1â2 hr of each other. The questionnaire was administered by a trained nurse, who also obtained the blood and urine samples. The length and weight of the baby at birth were also recorded. In three cases, cord blood was not collected; we therefore report on a sample size of 101.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7864</offset><text>Blood samples were processed and frozen at â80Â°C immediately in the hospital laboratory. Samples were collected in EDTA vacutainers; serum was immediately separated for folate, B12, and homocysteine analyses. Urine samples were also collected in acid-washed tubes and frozen at â80Â°C immediately. All samples were ultimately shipped on dry ice to the Mailman School of Public Health at Columbia University, and analyzed in the Trace Metals Core Laboratory; shipment required approximately 36 hr.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>8366</offset><text>Water As analyses</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8384</offset><text>A tube well water sample was obtained from 100 of the 101 womenâs primary well shortly after delivery, usually within a day, into 60-mL acid-cleaned polyethylene bottles. These were shipped to Columbia Universityâs Lamont Doherty Earth Observatory where they were acidified before analysis. Analytical procedures have previously been described in detail. For the present study, all water samples were analyzed using an axiom single-collector high-resolution inductively-coupled plasma mass spectrometer (HR ICP-MS) (Thermo Elemental, Erlanger, Germany). The analytical detection limit of the method is 0.1 Î¼g As/L; the standard deviation of a single measurement is conservatively estimated at 4 Î¼g/L for concentrations up to 150 Î¼g/L and 2% for samples &gt; 150 Î¼g/L.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>9157</offset><text>Total As measurements</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9179</offset><text>Urinary As concentrations were assayed by graphite furnace atomic absorption spectrophotometry (GFAA) using a PerkinElmer AAnalyst 600 system (PerkinElmer, Shelton, CT, USA) as described. Our laboratory participates in a quality control program coordinated by P. Weber at the Quebec Toxicology Center, Quebec City, Quebec, Canada. During the course of this study, intraclass correlation coefficients between our laboratoryâs values and samples calibrated at Weberâs laboratory were 0.99. The detection limit of the method is 2 Î¼g/L. Urinary As levels were also adjusted for urinary creatinine concentrations, which were determined by a standard colorimetric method based on Jaffeâs reaction, with reagents from Sigma Diagnostics (Sigma Chemical Company, St. Louis, MO, USA).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9961</offset><text>Maternal and cord venous whole blood samples were analyzed for total blood As concentration using a Perkin-Elmer Elan DRC II ICP-MS equipped with an AS 93+ autosampler as described elsewhere. Briefly, the As concentration of the standard solution used for instrument calibration was chosen to cover the expected range of As concentrations in the blood samples: 5, 25, and 50 Î¼g/L. Matrix suppression was compensated for by the use of iridium as an internal standard, selected to match to the ionization potential of As. Spectral interferences for As were resolved with dynamic reaction cell (DRC) technology by introducing oxygen as a second gas. The intraclass correlation coefficients between our laboratoryâs values and samples calibrated at Weberâs laboratory were 0.99. The detection limit of the method is 0.06 Î¼g/L.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>10790</offset><text>As metabolite measurements</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10817</offset><text>Urinary As and blood As metabolites were separated by high performance liquid chromatography (HPLC), with a PerkinElmer HPLC Series 200 (PerkinElmer), and then quantified by ICP-MS-DRC, using methods adapted from. Whole blood specimens were digested using methods from. Frozen samples were thawed and hemolyzed by mixing with 0.1 volume of 5.5% Triton X-100 in water. Then, 0.1 volume of 150 mM aqueous mercury chloride was added to displace trivalent As from protein thiols. After these samples were kept on ice for 1 min, they were deproteinized by mixing with one volume of 0.66 M ice cold HClO4 and centrifuged for 10 min at 4,000 rpm. The supernatant was mixed with mobile phase buffer and injected onto the HPLC column, connected to the ICP-MS-DRC. Calibration standards of a mixture of As metabolites were processed similar to blood samples to achieve the same pH and composition. Concentrations of calibration standards were chosen to cover the expected range of metabolite As concentrations in blood samples.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11835</offset><text>Excellent separation by HPLC coupled with very low detection limits of ICP-MS-DRC allowed us to detect MMA, DMA, As+3, and As+5, without online digestion of organic forms, with great precision in blood samples containing total As concentrations â¥ 10 Î¼g/L. The peaks for arsenocholine (AsC) and arsenobetaine (AsB), however, could not be resolved at these low concentrations. Therefore, we report the sum value for the concentrations of AsC + AsB in blood. For quality control we used two different types of samples. We purchased blood samples with known concentrations of 23 different elements (including As) from the Institut de Sante Publique du Quebec (Quebec, Canada), for validation of ICP-MS analyses. We also created our own set of blood specimens spiked with five metabolites (AsC, As+3, DMA, MMA, As+5) in three different concentrations to cover the expected range of As in study participant samples; these were spiked at the beginning of the study, aliquoted, and frozen. We ran both sets of quality control samples at the beginning of every working day and throughout the day, after every 10 samples. Interprecision during the course of this study for AsC, As+3, DMA, MMA, and As+5 was 5.8, 7.0, 3.2, 4.5, and 9.6%, respectively.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>13079</offset><text>To calculate the relative proportions of InAs, MMA, and DMA, the amounts of AsB and AsC were first subtracted from total blood As values. Because the detection limit of this method is 0.1 Î¼g/L per individual metabolite (with a total dilution factor of 22Ã for blood samples), metabolite data was captured only on the 30 participants with the highest As exposureâtotal blood As &gt; 10 Î¼g/L.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>13472</offset><text>Plasma folate, B12, and homocysteine</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>13509</offset><text>We analyzed plasma concentrations of folate and total cobalamin from maternal and cord blood samples by radioimmunoassay (Quantaphase II; Bio-Rad Laboratories, Richmond, CA, USA) as described previously. The within- and between-day coefficients of variation for folate were 3% and 11%, respectively, and those for cobalamin were 4% and 8%, respectively. Plasma homocysteine concentrations were measured by HPLC with fluorescence detection according to the method described by. The within- and between-day coefficients of variation for homocysteine were 5 and 8%, respectively.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>14086</offset><text>Statistical analyses</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14107</offset><text>We calculated descriptive statistics for sample characteristics of mothers and their newborns. Scatterplots were used to examine the relationships between maternal and cord blood measures. We tested bivariate correlations of variables of interest based on estimated Spearman correlation coefficients, and used paired t-tests to detect mean difference between maternal and cord measures or between maternal blood and urine measures. We used multiple linear regression analyses to determine whether maternal folate and homocysteine influence As metabolism, after adjusting for potential confounding factors. The outcomes variables, including maternal urinary As metabolites (%DMA, %MMA, and %InAs), maternal blood As metabolites, and cord blood As metabolites (%DMA, %MMA, %As+3, and % As+5) were regressed against the main predictors variables, folate, B12, and homocysteine, in separate models. Folate and homocysteine data were log-transformed to normalize their distributions. Control variables for analyses of maternal urinary metabolites included maternal age, parity, gestational age indicator (&lt; 37 weeks vs. â¥ 37 weeks), and log urinary creatinine. Control variables for maternal blood As metabolites were age and parity; for cord blood As metabolites, adjustments were made only for birth weight.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>15414</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15422</offset><text>Selected characteristics of the women and their husbands and newborns are provided in Table 1. Of note, on average, both the mothers and fathers were reasonably well educated, and 89% of the mothers could read and write. There were no significant differences when these characteristics were compared between the subset for whom blood As metabolite data was obtained and the remaining 71 women (data not shown).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15833</offset><text>Mean values of water As, urinary As, and total blood As concentrations, as well as plasma folate, B12, and homocysteine measurements are summarized in Table 2. The mean maternal tube well water As concentration was 90.5 Î¼g/L, with 28% of the wells exceeding the Bangladesh standard of 50 Î¼g/L, and 38% exceeding the World Health Organization standard of 10 Î¼g/L. Water As was significantly associated with both maternal and cord total blood As (r = 0.40, p &lt; 0.0001; and r = 0.35, p = 0.0003, respectively). Water As was also significantly associated with maternal urinary As (micrograms per gram creatinine) (r = 0.52; p &lt; 0.0001).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16469</offset><text>The mean cord total blood As values of 15.7 Î¼g/L in the total sample (n = 101) and 23.13 mg/L in the subset (n = 30) exceeded the mean maternal total blood As of 11.9 Î¼g/L (n = 101) and 20.02 mg/L (n = 30) by 32% (p &lt; 0.0001) and 16% (p &lt; 0.0001), respectively. This statistically significant finding is likely attributable to the greater concentration of hemoglobin in cord blood. The ranges for both of these parameters were extremely wide, undoubtedly reflecting, in part, the wide range of water As (Table 2). The relative proportions of As+3, As+5, MMA, and DMA were virtually identical in terms of mean values in maternal and cord blood (Table 3). In each case the mean proportions were 43% DMA, 30% MMA, 13% As3+, and 13% As5+. Compared with maternal urine (Table 3), maternal blood contained substantially higher proportions of InAs (i.e., As+3 + As+5) and MMA but less DMA. The spearman correlation coefficient between the sum of urinary As metabolites and the sum of blood As metabolites is 0.88.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17478</offset><text>For maternal and cord blood As analyses, we compared the total As concentration with the sum of As metabolite concentration values obtained by HPLC-ICP-MS. To do so, we adjusted for the HPLC percent recovery. The same approach was used to compare total urine As concentrations obtained by GFAA to those derived from the sum of urinary As metabolites via HPLC-ICP-MS. Recoveries for the HPLC-ICP-MS methods were 57% for cord blood (n = 30), 69% for maternal blood (n = 30), and 89% for maternal urine (n = 101). Comparison of the recovered-adjusted sum of As metabolite concentrations with the measured total As concentrations, for cord blood, maternal blood, and maternal urine, shows good agreement (Table 3) with concordance correlation coefficient of 0.87, 0.91, and 0.99, respectively.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18268</offset><text>The mean cord plasma folate and B12 values (52.7 nmol/L and 370.4 pmol/L, respectively) were more than twice those in maternal blood (p &lt; 0.0001), whereas cord plasma homocysteine was 11% lower than maternal plasma homocysteine (p &lt; 0.0001) (Table 2). Inadequate plasma folate during pregnancy, defined here as &lt; 6.8 nmol/L, was found in 1% of the study participants. Vitamin B12 deficiency, defined here as &lt; 185 pmol/L based on nonpregnant reference values previously reported, was found in 58.9% of the women in this study (; B12 pregnancy-specific reference ranges are not available). The prevalence of hyperhomocysteinemia was low (1.9%), based on non-pregnant cutoffs of &gt; 10.4 Î¼mol/L for women from the Third National Health and Nutrition Examination Survey.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19035</offset><text>Table 4 summarizes the results from multiple linear regression analyses used to determine whether maternal plasma folate and homocysteine concentrations influence As metabolism. Maternal homocysteine was a strong predictor of %DMA in maternal urine, maternal blood, and cord blood (Î² = â6.2, p &lt; 0.02; Î² = â10.9, p &lt; 0.04; and Î² = â13.7, p &lt; 0.04, respectively). A positive association was also found between maternal homocysteine and urinary InAs (Î² = 0.84, p &lt; 0.009), maternal blood As5+ (Î² = 1.3, p &lt; 0.02), and cord blood As5+ (Î² = 1.3, p &lt; 0.04). Maternal folate was inversely associated with maternal blood As5+ (Î² = â0.56, p &lt; 0.05), and maternal B12 was inversely associated with cord blood As5+ (Î² = â1.2, p &lt; 0.01).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19786</offset><text>We used multiple linear regression analyses to examine the predictors of maternal total blood As. We hypothesized that total blood As would decline with increasing parity, because it is known that maternal blood lead declines with parity due to the gradual âsheddingâ of the maternal body burden into each offspring. Because total blood As and water As had skewed distribution, these variables were log-transformed. Water As was positively associated with maternal total blood As, controlling for parity (Î² = 0.074, p &lt; 0.0001). As hypothesized, parity was inversely associated with maternal total blood As (r = â0.22, p = 0.025), but after adjustment for water As, this association was only marginally significant (p = 0.094). Parity was not associated with cord total blood As before or after controlling for maternal total blood As.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>20629</offset><text>There was a strong association between the maternal and cord total blood As concentrations (r = 0.84, Î² = 0.94, p &lt; 0.0001) (Figure 1). In the subset of 30 maternalâcord blood pairs for which blood As metabolite data were detectable, there were also strong associations for each As metabolite, as depicted in Figure 2.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>20951</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>20962</offset><text>The appearance of As in cord blood is extremely troubling because gestation is a period of high sensitivity to carcinogens. have demonstrated that adult mice that had been briefly exposed to As during their own fetal development (during gestation days 8â18) developed tumors of the liver, ovary, adrenal gland, and lung, as well as preneoplastic lesions of the uterus and oviduct. Recently, the same group reported that when pregnant mice were exposed to As3+ in their drinking water, As3+ behaved as a complete carcinogen in male offspring, which subsequently developed liver, lung, kidney, and adrenal gland tumors. In addition, when As3+ exposure was combined with either in utero or postnatal estrogen, liver lesions were enhanced and bladder lesions also developed.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>21735</offset><text>Relatively little research has examined the extent to which As exposure in pregnant women leads to exposure of the fetus to As. Two previous reports examined As concentrations in maternalâcord blood pairs. A 1991 report described findings derived from 82 births from three cities in Taiwan. Compared with the current study, their total blood As concentrations were low, with mean maternal and cord blood levels of only 7 and 8 Î¼g As/L, respectively. In that low range, the authors reported a correlation between maternal and cord total blood As of 0.57 (p &lt; 0.001). A second study of 11 births in northern Argentina also involved relatively low blood As concentrations and found a comparable association. Our present study is unique in that the study population had a very wide range of water As exposures, it employed a more sensitive and precise analytical method (i.e., ICP-MS-DRC), and, in addition to total blood As, it measured blood As metabolites, urinary As metabolites, and plasma folate, B12, and homocysteine concentrations. Across the range of water As exposures in this study population (0.1â661.0 Î¼g/L), the correlation between maternal and cord total blood As was very strong (r = 0.84, p &lt; 0.0001).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>22957</offset><text>An additional concern regarding exposure to As during the prenatal period is the possible effects on birth outcomes. studied 844 births in two towns in Chile, one of which (Valparaiso) had water As &lt; 1 Î¼g/L and the other (Antofagasta) had a range of 33â53 Î¼g/L. They reported that, after controlling for covariates, the mean birth weight in Antofagasta was 57 g lower that that in the nonexposed group, but this difference across towns did not achieve statistical significance. A much larger retrospective study of 18,259 firstborn singleton live births took place in two rural regions of Taiwan which had low and high (up to 3.59 mg/L) water As concentrations. After controlling for maternal age, marital status, maternal education, and sex of the infant, observed a significant difference in birth weight of 29 g between exposed and ânonexposedâ regions (p = 0.002). However, the ecologic nature of this study, and its use of âextreme points of contrastâ limit the ability to make causal inferences.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23971</offset><text>An additional concern about transplacental transfer of As and its metabolites during the prenatal period relates to our recent findings of a dose-dependent adverse relationship between As exposure and intelligence in young. Two separate cross-sectional studies of Bangladeshi children, one in 10-year-old children and the second in 6-year-old children, find deficits in visual motor functioning associated with As exposure. At this point it is unclear how much of these deficits can be attributed to prenatal as opposed to postnatal exposures.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>24515</offset><text>Household well water As concentrations obtained in the perinatal period proved to be predictive of both maternal and cord blood As, but these associations were considerably weaker (r = 0.40 and 0.35, respectively) than that with maternal urine As (r = 0.51). The proportion of DMA excreted in maternal urine (87%) was quite high compared with that observed in our previous cross-sectional study of men and nonpregnant women (71%). This may be attributed partly to changes in As metabolism during pregnancy or to the fact that women in the current study were supplemented with folic acid, which enhances As methylation.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25134</offset><text>We observed that compared with maternal urine, maternal blood contained higher proportions of MMA and InAs and lower DMA. This finding is consistent with literature reports indicating that methylated As species have shorter half-lives of elimination than inorganic forms. The literature concerning the proportions of various As metabolites in human blood is scant, but our findings are coherent with those of, who reportedly found the proportions of InAs, MMA, and DMA to be 19.4, 49.2, and 31.4%, respectively, in adults.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25657</offset><text>Although the utility of blood As as a bio-marker of As exposure is only now being established, our findings do make it clear that maternalâfetal transport of As readily occurs. Importantly, the strong associations reported here between maternal and cord blood As metabolites demonstrate that the fetus is exposed to the full range of As species generated during As metabolism, although we cannot infer whether this occurs through passive diffusion of As metabolites or fetal metabolism of InAs.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>26154</offset><text>Folate and homocysteine appear to be important determinants of As methylation. The importance of these parameters may be heightened during pregnancy, due to the increased demand for folate for fetal development. Animal studies have shown that insufficient folate intake decreased InAs bio-transformation and excretion, and increased tissue retention and toxicity, but until recently few human studies have focused on the role of folate in As metabolism. Folate deficiency during pregnancy has been associated with various complications, including placental abruption, preeclampsia, and spontaneous abortion, and it is well established that folic acid supplementation prevents neural tube defects and reduces the incidence of low birth weight. However, in developing countries folate deficiency among unsupplemented pregnant women is still a public health concern. Studies to delineate more fully the risks to pregnant women who are both folate deficient and exposed to InAs in drinking water should be a high priority.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>27173</offset><text>The low prevalence of folate deficiency among these participants likely reflects the fact that these women received folic acid supplements during pregnancy. Our findings are also consistent with previous reports that blood folate concentrations of the newborn are significantly higher than maternal levels, presumably reflecting the in utero active transport process. Our observation that fetal B12 concentrations were more than twice those of maternal levels is also in line with other reports.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>27669</offset><text>In summary, we have demonstrated strong relationships between maternal and cord total blood As and blood As metabolite concentrations, which indicate that newborn children in Matlab, and likely other regions of Bangladesh, are exposed to hazardous concentrations of As metabolites during the prenatal period. Given the findings reported here, we conclude that As metabolism may be impaired and its toxicity heightened in populations, such as in Bangladesh, where foods are not folic acid enriched and prenatal supplements are not always available. Interestingly, homocysteineâeven at levels that are within the normal range and even after folic acid supplementationâis associated with decreased As methylation. Efforts to reduce As exposure should be a high priority, because this element has adverse effects on early childhood development, is a well-established carcinogen, and has potential synergistic effects with other co-exposures.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">footnote</infon><offset>28611</offset><text>We acknowledge I. Haque, S. Yeasmin, and A.M. Wahedul Hoque.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">footnote</infon><offset>28672</offset><text>This work was supported by National Institute of Environmental Health Sciences grants P42 ES10349, P30 ES09089, R01 ESO11601, the Mailman School of Public Health, Lamont-Doherty Earth Observatory, and the Earth Institute at Columbia University.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>28917</offset><text>References</text></passage><passage><infon key="fpage">629</infon><infon key="lpage">631</infon><infon key="name_0">surname:Ahmad;given-names:SA</infon><infon key="name_1">surname:Sayed;given-names:MH</infon><infon key="name_2">surname:Barua;given-names:S</infon><infon key="name_3">surname:Khan;given-names:MH</infon><infon key="name_4">surname:Faruquee;given-names:MH</infon><infon key="name_5">surname:Jalil;given-names:A</infon><infon key="pub-id_pmid">11445518</infon><infon key="section_type">REF</infon><infon key="source">Environ Health Perspect</infon><infon key="type">ref</infon><infon key="volume">109</infon><infon key="year">2001</infon><offset>28928</offset><text>Arsenic in drinking water and pregnancy outcomes</text></passage><passage><infon key="fpage">573</infon><infon key="issue">suppl 3</infon><infon key="lpage">594</infon><infon key="name_0">surname:Anderson;given-names:LM</infon><infon key="name_1">surname:Diwan;given-names:BA</infon><infon key="name_2">surname:Fear;given-names:NT</infon><infon key="name_3">surname:Roman;given-names:E</infon><infon key="pub-id_pmid">10852857</infon><infon key="section_type">REF</infon><infon key="source">Environ Health Perspect</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">2000</infon><offset>28977</offset><text>Critical windows of exposure for childrenâs health: cancer in human epidemiological studies and neoplasms in experimental animal models</text></passage><passage><infon key="fpage">327</infon><infon key="lpage">335</infon><infon key="name_0">surname:Aposhian;given-names:HV</infon><infon key="name_1">surname:Zakharyan;given-names:RA</infon><infon key="name_2">surname:Avram;given-names:MD</infon><infon key="name_3">surname:Sampayo-Reyes;given-names:A</infon><infon key="name_4">surname:Wollenberg;given-names:ML</infon><infon key="pub-id_pmid">15276412</infon><infon key="section_type">REF</infon><infon key="source">Toxicol Appl Pharmacol</infon><infon key="type">ref</infon><infon key="volume">198</infon><infon key="year">2004</infon><offset>29115</offset><text>A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxification of the trivalent arsenic species</text></passage><passage><infon key="fpage">77</infon><infon key="issue">1</infon><infon key="lpage">78</infon><infon key="name_0">surname:Borzsonyi;given-names:M</infon><infon key="name_1">surname:Bereczky;given-names:A</infon><infon key="name_2">surname:Rudnai;given-names:P</infon><infon key="name_3">surname:Csanady;given-names:M</infon><infon key="name_4">surname:Horvath;given-names:A</infon><infon key="pub-id_pmid">1580796</infon><infon key="section_type">REF</infon><infon key="source">Arch Toxicol</infon><infon key="type">ref</infon><infon key="volume">66</infon><infon key="year">1992</infon><offset>29265</offset><text>Epidemiological studies on human subjects exposed to arsenic in drinking water in southeast Hungary</text></passage><passage><infon key="fpage">71</infon><infon key="issue">1</infon><infon key="lpage">79</infon><infon key="name_0">surname:Buchet;given-names:JP</infon><infon key="name_1">surname:Lauwerys;given-names:R</infon><infon key="name_2">surname:Roels;given-names:H</infon><infon key="pub-id_pmid">6894292</infon><infon key="section_type">REF</infon><infon key="source">Int Arch Occup Environ Health</infon><infon key="type">ref</infon><infon key="volume">48</infon><infon key="year">1981</infon><offset>29365</offset><text>Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man</text></passage><passage><infon key="fpage">241</infon><infon key="issue">3</infon><infon key="lpage">248</infon><infon key="name_0">surname:Chen;given-names:YC</infon><infon key="name_1">surname:Guo;given-names:YL</infon><infon key="name_2">surname:Su;given-names:HJ</infon><infon key="name_3">surname:Hsueh;given-names:YM</infon><infon key="name_4">surname:Smith;given-names:TJ</infon><infon key="name_5">surname:Ryan;given-names:LM</infon><infon key="pub-id_pmid">12661181</infon><infon key="section_type">REF</infon><infon key="source">J Occup Environ Med</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2003a</infon><offset>29516</offset><text>Arsenic methylation and skin cancer risk in southwestern Taiwan</text></passage><passage><infon key="fpage">303</infon><infon key="issue">4</infon><infon key="lpage">310</infon><infon key="name_0">surname:Chen;given-names:YC</infon><infon key="name_1">surname:Su;given-names:HJ</infon><infon key="name_2">surname:Guo;given-names:YL</infon><infon key="name_3">surname:Hsueh;given-names:YM</infon><infon key="name_4">surname:Smith;given-names:TJ</infon><infon key="name_5">surname:Ryan;given-names:LM</infon><infon key="pub-id_pmid">12846360</infon><infon key="section_type">REF</infon><infon key="source">Cancer Causes Control</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2003b</infon><offset>29580</offset><text>Arsenic methylation and bladder cancer risk in Taiwan</text></passage><passage><infon key="fpage">513</infon><infon key="lpage">518</infon><infon key="name_0">surname:Cheng;given-names:ZY</infon><infon key="name_1">surname:Zheng;given-names:Y</infon><infon key="name_2">surname:Mortlock;given-names:R</infon><infon key="name_3">surname:van Geen;given-names:A</infon><infon key="section_type">REF</infon><infon key="source">Anal Bioanal Chem</infon><infon key="type">ref</infon><infon key="volume">379</infon><infon key="year">2004</infon><offset>29634</offset><text>Rapid multi-element analysis of groundwater by high-resolution inductively coupled plasma mass spectrometry</text></passage><passage><infon key="fpage">86</infon><infon key="issue">2</infon><infon key="lpage">91</infon><infon key="name_0">surname:Chowdhury;given-names:AM</infon><infon key="pub-id_pmid">15298124</infon><infon key="section_type">REF</infon><infon key="source">Sci Am</infon><infon key="type">ref</infon><infon key="volume">291</infon><infon key="year">2004</infon><offset>29742</offset><text>Arsenic crisis in Bangladesh</text></passage><passage><infon key="fpage">1358</infon><infon key="lpage">1360</infon><infon key="name_0">surname:Christenson;given-names:Rh</infon><infon key="name_1">surname:Dent;given-names:Ga</infon><infon key="name_2">surname:Tuszynski;given-names:A</infon><infon key="pub-id_pmid">4017241</infon><infon key="section_type">REF</infon><infon key="source">Clin Chem</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">1985</infon><offset>29771</offset><text>Two radioassays for serum vitamin B12 and folate determination compared in a reference interval study</text></passage><passage><infon key="fpage">185</infon><infon key="issue">2</infon><infon key="lpage">190</infon><infon key="name_0">surname:Concha;given-names:G</infon><infon key="name_1">surname:Vogler;given-names:G</infon><infon key="name_2">surname:Lezcano;given-names:D</infon><infon key="name_3">surname:Nermell;given-names:B</infon><infon key="name_4">surname:Vahter;given-names:M</infon><infon key="pub-id_pmid">9742656</infon><infon key="section_type">REF</infon><infon key="source">Toxicol Sci</infon><infon key="type">ref</infon><infon key="volume">44</infon><infon key="year">1998</infon><offset>29873</offset><text>Exposure to inorganic arsenic metabolites during early human development</text></passage><passage><infon key="fpage">77</infon><infon key="issue">1â3</infon><infon key="lpage">91</infon><infon key="name_0">surname:Csanaky;given-names:I</infon><infon key="name_1">surname:Nemeti;given-names:B</infon><infon key="name_2">surname:Gregus;given-names:Z</infon><infon key="pub-id_pmid">12504344</infon><infon key="section_type">REF</infon><infon key="source">Toxicology</infon><infon key="type">ref</infon><infon key="volume">183</infon><infon key="year">2003</infon><offset>29946</offset><text>Dose-dependent bio-transformation of arsenite in ratsânot S-adenosylmethionine depletion impairs arsenic methylation at high dose</text></passage><passage><infon key="fpage">988</infon><infon key="issue">10</infon><infon key="lpage">995</infon><infon key="name_0">surname:Davis;given-names:CD</infon><infon key="name_1">surname:Uthus;given-names:EO</infon><infon key="pub-id_pmid">15522834</infon><infon key="section_type">REF</infon><infon key="source">Exp Biol Med (Maywood)</infon><infon key="type">ref</infon><infon key="volume">229</infon><infon key="year">2004</infon><offset>30078</offset><text>DNA methylation, cancer susceptibility, and nutrient interactions</text></passage><passage><infon key="fpage">385</infon><infon key="issue">4</infon><infon key="lpage">433</infon><infon key="name_0">surname:DeSesso;given-names:JM</infon><infon key="name_1">surname:Jacobson;given-names:CF</infon><infon key="name_2">surname:Scialli;given-names:AR</infon><infon key="name_3">surname:Farr;given-names:CH</infon><infon key="name_4">surname:Holson;given-names:JF</infon><infon key="pub-id_pmid">9717692</infon><infon key="section_type">REF</infon><infon key="source">Reprod Toxicol</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">1998</infon><offset>30144</offset><text>An assessment of the developmental toxicity of inorganic arsenic</text></passage><passage><infon key="fpage">1372</infon><infon key="issue">6</infon><infon key="lpage">1377</infon><infon key="name_0">surname:Gamble;given-names:MV</infon><infon key="name_1">surname:Ahsan;given-names:H</infon><infon key="name_2">surname:Liu;given-names:X</infon><infon key="name_3">surname:Factor-Litvak;given-names:P</infon><infon key="name_4">surname:Ilievski;given-names:V</infon><infon key="name_5">surname:Slavkovich;given-names:V</infon><infon key="pub-id_pmid">15941889</infon><infon key="section_type">REF</infon><infon key="source">Am J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">81</infon><infon key="year">2005a</infon><offset>30209</offset><text>Folate and cobalamin deficiencies and hyperhomocysteinemia in Bangladesh</text></passage><passage><infon key="fpage">1683</infon><infon key="lpage">1688</infon><infon key="name_0">surname:Gamble;given-names:MV</infon><infon key="name_1">surname:Liu;given-names:X</infon><infon key="name_2">surname:Ahsan;given-names:H</infon><infon key="name_3">surname:Pilsner;given-names:R</infon><infon key="name_4">surname:Ilievski;given-names:V</infon><infon key="name_5">surname:Slavkovich;given-names:V</infon><infon key="pub-id_pmid">16330347</infon><infon key="section_type">REF</infon><infon key="source">Environ Health Perspect</infon><infon key="type">ref</infon><infon key="volume">113</infon><infon key="year">2005b</infon><offset>30282</offset><text>Folate, homocysteine and arsenic metabolism in arsenic-exposed individuals in Bangladesh</text></passage><passage><infon key="fpage">1093</infon><infon key="lpage">1101</infon><infon key="name_0">surname:Gamble;given-names:MV</infon><infon key="name_1">surname:Liu;given-names:X</infon><infon key="name_2">surname:Ahsan;given-names:H</infon><infon key="name_3">surname:Pilsner;given-names:JR</infon><infon key="name_4">surname:Illievski;given-names:V</infon><infon key="name_5">surname:Slavkovich;given-names:V</infon><infon key="pub-id_pmid">17093162</infon><infon key="section_type">REF</infon><infon key="source">Am J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">84</infon><infon key="year">2006</infon><offset>30371</offset><text>Folate and arsenic metabolism: a double-blind placebo controlled folic acid supplementation trial in Bangladesh</text></passage><passage><infon key="fpage">1867</infon><infon key="issue">15</infon><infon key="lpage">1873</infon><infon key="name_0">surname:George;given-names:L</infon><infon key="name_1">surname:Mills;given-names:JL</infon><infon key="name_2">surname:Johansson;given-names:AL</infon><infon key="name_3">surname:Nordmark;given-names:A</infon><infon key="name_4">surname:Olander;given-names:B</infon><infon key="name_5">surname:Granath;given-names:F</infon><infon key="pub-id_pmid">12377085</infon><infon key="section_type">REF</infon><infon key="source">JAMA</infon><infon key="type">ref</infon><infon key="volume">288</infon><infon key="year">2002</infon><offset>30483</offset><text>Plasma folate levels and risk of spontaneous abortion</text></passage><passage><infon key="fpage">784</infon><infon key="lpage">791</infon><infon key="name_0">surname:Guerra-Shinohara;given-names:EM</infon><infon key="name_1">surname:Paiva;given-names:Aa</infon><infon key="name_2">surname:Rondo;given-names:PHC</infon><infon key="name_3">surname:Yamasaki;given-names:K</infon><infon key="name_4">surname:Terzi;given-names:CA</infon><infon key="name_5">surname:DâAlmeida;given-names:V</infon><infon key="pub-id_pmid">12135215</infon><infon key="section_type">REF</infon><infon key="source">BJOG</infon><infon key="type">ref</infon><infon key="volume">109</infon><infon key="year">2002</infon><offset>30537</offset><text>Relationship between total homocysteine and folate levels in pregnant women and their newborn babies according to maternal serum levels of vitamin B12</text></passage><passage><infon key="fpage">225</infon><infon key="issue">2â3</infon><infon key="lpage">233</infon><infon key="name_0">surname:Hall;given-names:M</infon><infon key="name_1">surname:Chen;given-names:Y</infon><infon key="name_2">surname:Ahsan;given-names:H</infon><infon key="name_3">surname:Slavkovich;given-names:V</infon><infon key="name_4">surname:van Geen;given-names:A</infon><infon key="name_5">surname:Parvez;given-names:F</infon><infon key="pub-id_pmid">16860454</infon><infon key="section_type">REF</infon><infon key="source">Toxicology</infon><infon key="type">ref</infon><infon key="volume">225</infon><infon key="year">2006</infon><offset>30688</offset><text>Blood arsenic as a biomarker of arsenic exposure: results from a prospective study</text></passage><passage><infon key="fpage">593</infon><infon key="issue">5</infon><infon key="lpage">602</infon><infon key="name_0">surname:Hopenhayn;given-names:C</infon><infon key="name_1">surname:Ferreccio;given-names:C</infon><infon key="name_2">surname:Browning;given-names:SR</infon><infon key="name_3">surname:Huang;given-names:B</infon><infon key="name_4">surname:Peralta;given-names:C</infon><infon key="name_5">surname:Gibb;given-names:H</infon><infon key="pub-id_pmid">14501275</infon><infon key="section_type">REF</infon><infon key="source">Epidemiology</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2003</infon><offset>30771</offset><text>Arsenic exposure from drinking water and birth weight</text></passage><passage><infon key="fpage">667</infon><infon key="lpage">673</infon><infon key="name_0">surname:Hopenhayn-Rich;given-names:C</infon><infon key="name_1">surname:Browning;given-names:SR</infon><infon key="name_2">surname:Hertz-Picciotto;given-names:I</infon><infon key="name_3">surname:Ferreccio;given-names:C</infon><infon key="name_4">surname:Peralta;given-names:C</infon><infon key="name_5">surname:Gibb;given-names:H</infon><infon key="pub-id_pmid">10903622</infon><infon key="section_type">REF</infon><infon key="source">Environ Health Perspect</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">2000</infon><offset>30825</offset><text>Chronic arsenic exposure and risk of infant mortality in two areas of Chile</text></passage><passage><infon key="fpage">589</infon><infon key="issue">8</infon><infon key="lpage">596</infon><infon key="name_0">surname:Hsueh;given-names:YM</infon><infon key="name_1">surname:Chiou;given-names:HY</infon><infon key="name_2">surname:Huang;given-names:YL</infon><infon key="name_3">surname:Wu;given-names:WL</infon><infon key="name_4">surname:Huang;given-names:CC</infon><infon key="name_5">surname:Yang;given-names:MH</infon><infon key="pub-id_pmid">9264271</infon><infon key="section_type">REF</infon><infon key="source">Cancer Epidemiol Biomarkers Prev</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">1997</infon><offset>30901</offset><text>Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer</text></passage><passage><infon key="fpage">99</infon><infon key="issue">2</infon><infon key="lpage">108</infon><infon key="name_0">surname:Milton;given-names:AH</infon><infon key="name_1">surname:Hasan;given-names:Z</infon><infon key="name_2">surname:Shahidullah;given-names:SM</infon><infon key="name_3">surname:Sharimin;given-names:S</infon><infon key="name_4">surname:Jakarya;given-names:MD</infon><infon key="name_5">surname:Rahman;given-names:M</infon><infon key="pub-id_pmid">15203455</infon><infon key="section_type">REF</infon><infon key="source">Int J Environ Health Res</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2004</infon><offset>30989</offset><text>Association between nutritional status and arsenicosis due to chronic arsenic exposure in Bangladesh</text></passage><passage><infon key="fpage">499</infon><infon key="lpage">503</infon><infon key="name_0">surname:Molloy;given-names:AM</infon><infon key="name_1">surname:Mills;given-names:JL</infon><infon key="name_2">surname:McParlin;given-names:J</infon><infon key="name_3">surname:Kirke;given-names:PN</infon><infon key="name_4">surname:Scott;given-names:JM</infon><infon key="name_5">surname:Daly;given-names:S</infon><infon key="pub-id_pmid">11904614</infon><infon key="section_type">REF</infon><infon key="source">Am J Obstet Gynecol</infon><infon key="type">ref</infon><infon key="volume">186</infon><infon key="year">2002</infon><offset>31090</offset><text>Maternal and fetal plasma homocysteine concentrations at birth: the influence of folate, vitamin B12, and the 5,10-methylenetetrahydrofolate reductase 677C â T variant</text></passage><passage><infon key="section_type">REF</infon><infon key="source">Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline</infon><infon key="type">ref</infon><infon key="year">1998</infon><offset>31260</offset></passage><passage><infon key="section_type">REF</infon><infon key="source">Arsenic in Drinking Water</infon><infon key="type">ref</infon><infon key="year">1999</infon><offset>31261</offset></passage><passage><infon key="fpage">1575</infon><infon key="lpage">1579</infon><infon key="name_0">surname:Nixon;given-names:DE</infon><infon key="name_1">surname:Mussmann;given-names:GV</infon><infon key="name_2">surname:Ecktahdahl;given-names:SJ</infon><infon key="name_3">surname:Moyer;given-names:TP</infon><infon key="pub-id_pmid">1893592</infon><infon key="section_type">REF</infon><infon key="source">Clin Chem</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">1991</infon><offset>31262</offset><text>Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry</text></passage><passage><infon key="fpage">133</infon><infon key="lpage">139</infon><infon key="name_0">surname:Obeid;given-names:R</infon><infon key="name_1">surname:Munz;given-names:W</infon><infon key="name_2">surname:Werner;given-names:S</infon><infon key="name_3">surname:Herrmann;given-names:W</infon><infon key="pub-id_pmid">16002811</infon><infon key="section_type">REF</infon><infon key="source">Am J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">82</infon><infon key="year">2005</infon><offset>31395</offset><text>Biochemical indexes of the B vitamins in cord serum are predicted by maternal B vitamin status</text></passage><passage><infon key="fpage">290</infon><infon key="issue">2</infon><infon key="lpage">292</infon><infon key="name_0">surname:Pfeiffer;given-names:CM</infon><infon key="name_1">surname:Huff;given-names:DL</infon><infon key="name_2">surname:Gunter;given-names:EW</infon><infon key="pub-id_pmid">9931056</infon><infon key="section_type">REF</infon><infon key="source">Clin Chem</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">1999</infon><offset>31490</offset><text>Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting</text></passage><passage><infon key="fpage">331</infon><infon key="lpage">336</infon><infon key="name_0">surname:Pi;given-names:J</infon><infon key="name_1">surname:Yamauchi;given-names:H</infon><infon key="name_2">surname:Kumagai;given-names:Y</infon><infon key="name_3">surname:Sun;given-names:G</infon><infon key="name_4">surname:Yoshida;given-names:T</infon><infon key="name_5">surname:Aikawa;given-names:H</infon><infon key="pub-id_pmid">11940449</infon><infon key="section_type">REF</infon><infon key="source">Environ Health Perspect</infon><infon key="type">ref</infon><infon key="volume">110</infon><infon key="year">2002</infon><offset>31596</offset><text>Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water</text></passage><passage><infon key="fpage">1997S</infon><infon key="issue">6</infon><infon key="lpage">2002S</infon><infon key="name_0">surname:Picciano;given-names:MF</infon><infon key="pub-id_pmid">12771353</infon><infon key="section_type">REF</infon><infon key="source">J Nutr</infon><infon key="type">ref</infon><infon key="volume">133</infon><infon key="year">2003</infon><offset>31726</offset><text>Pregnancy and lactation: physiological adjustments, nutritional requirements and the role of dietary supplements</text></passage><passage><infon key="name_0">surname:Reuter;given-names:W</infon><infon key="name_1">surname:Neubauer;given-names:K</infon><infon key="section_type">REF</infon><infon key="source">Speciation of Five Arsenic Compound in Urine by HPLC/ICP-MS</infon><infon key="type">ref</infon><infon key="year">2003</infon><offset>31839</offset></passage><passage><infon key="fpage">394</infon><infon key="issue">3</infon><infon key="lpage">404</infon><infon key="name_0">surname:Rossman;given-names:TG</infon><infon key="name_1">surname:Uddin;given-names:AN</infon><infon key="name_2">surname:Burns;given-names:FJ</infon><infon key="pub-id_pmid">15276419</infon><infon key="section_type">REF</infon><infon key="source">Toxicol Appl Pharmacol</infon><infon key="type">ref</infon><infon key="volume">198</infon><infon key="year">2004</infon><offset>31840</offset><text>Evidence that arsenite acts as a cocarcinogen in skin cancer</text></passage><passage><infon key="fpage">381</infon><infon key="issue">4</infon><infon key="lpage">387</infon><infon key="name_0">surname:Slot;given-names:C</infon><infon key="pub-id_pmid">5838275</infon><infon key="section_type">REF</infon><infon key="source">Scand J Clin Lab Invest</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">1965</infon><offset>31901</offset><text>Plasma creatinine determination. A new and specific Jaffe reaction method</text></passage><passage><infon key="fpage">59</infon><infon key="issue">1</infon><infon key="lpage">65</infon><infon key="name_0">surname:Soong;given-names:YK</infon><infon key="name_1">surname:Tseng;given-names:R</infon><infon key="name_2">surname:Liu;given-names:C</infon><infon key="name_3">surname:Lin;given-names:PW</infon><infon key="pub-id_pmid">1679111</infon><infon key="section_type">REF</infon><infon key="source">J Formos Med Assoc</infon><infon key="type">ref</infon><infon key="volume">90</infon><infon key="year">1991</infon><offset>31975</offset><text>Lead, cadmium, arsenic, and mercury levels in maternal and fetal cord blood</text></passage><passage><infon key="fpage">167</infon><infon key="issue">2</infon><infon key="lpage">174</infon><infon key="name_0">surname:Spiegelstein;given-names:O</infon><infon key="name_1">surname:Lu;given-names:X</infon><infon key="name_2">surname:Le;given-names:XC</infon><infon key="name_3">surname:Troen;given-names:A</infon><infon key="name_4">surname:Selhub;given-names:J</infon><infon key="name_5">surname:Melnyk;given-names:S</infon><infon key="pub-id_pmid">14581169</infon><infon key="section_type">REF</infon><infon key="source">Toxicol Lett</infon><infon key="type">ref</infon><infon key="volume">145</infon><infon key="year">2003</infon><offset>32051</offset><text>Effects of dietary folate intake and folate binding protein-1 (Folbp1) on urinary speciation of sodium arsenate in mice</text></passage><passage><infon key="fpage">20</infon><infon key="lpage">24</infon><infon key="name_0">surname:Steegers-Theunissen;given-names:RPM</infon><infon key="name_1">surname:Wathen;given-names:NC</infon><infon key="name_2">surname:Eskes;given-names:TKAB</infon><infon key="name_3">surname:van Raaij-Selten;given-names:B</infon><infon key="name_4">surname:Chard;given-names:T</infon><infon key="pub-id_pmid">8988690</infon><infon key="section_type">REF</infon><infon key="source">Br J Obstet Gynaecol</infon><infon key="type">ref</infon><infon key="volume">104</infon><infon key="year">1997</infon><offset>32171</offset><text>Maternal and fetal levels of methionine and homocysteine in early human pregnancy</text></passage><passage><infon key="fpage">993</infon><infon key="lpage">1016</infon><infon key="name_0">surname:Tamura;given-names:T</infon><infon key="name_1">surname:Picciano;given-names:MF</infon><infon key="pub-id_pmid">16685040</infon><infon key="section_type">REF</infon><infon key="source">Am J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">83</infon><infon key="year">2006</infon><offset>32253</offset><text>Folate and human reproduction</text></passage><passage><infon key="fpage">319</infon><infon key="issue">3</infon><infon key="lpage">326</infon><infon key="name_0">surname:Thomas;given-names:DJ</infon><infon key="name_1">surname:Waters;given-names:SB</infon><infon key="name_2">surname:Styblo;given-names:M</infon><infon key="pub-id_pmid">15276411</infon><infon key="section_type">REF</infon><infon key="source">Toxicol Appl Pharmacol</infon><infon key="type">ref</infon><infon key="volume">198</infon><infon key="year">2004</infon><offset>32283</offset><text>Elucidating the pathway for arsenic methylation</text></passage><passage><infon key="fpage">299</infon><infon key="issue">3</infon><infon key="lpage">308</infon><infon key="name_0">surname:Tseng;given-names:CH</infon><infon key="name_1">surname:Huang;given-names:YK</infon><infon key="name_2">surname:Huang;given-names:YL</infon><infon key="name_3">surname:Chung;given-names:CJ</infon><infon key="name_4">surname:Yang;given-names:MH</infon><infon key="name_5">surname:Chen;given-names:CJ</infon><infon key="pub-id_pmid">16039941</infon><infon key="section_type">REF</infon><infon key="source">Toxicol Appl Pharmacol</infon><infon key="type">ref</infon><infon key="volume">206</infon><infon key="year">2005</infon><offset>32331</offset><text>Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan</text></passage><passage><infon key="fpage">209</infon><infon key="lpage">217</infon><infon key="name_0">surname:Vahter;given-names:M</infon><infon key="section_type">REF</infon><infon key="source">Toxicol Lett</infon><infon key="type">ref</infon><infon key="volume">112â113</infon><infon key="year">2000</infon><offset>32462</offset><text>Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity</text></passage><passage><infon key="fpage">1</infon><infon key="issue">1</infon><infon key="lpage">5</infon><infon key="name_0">surname:Vahter;given-names:M</infon><infon key="name_1">surname:Concha;given-names:G</infon><infon key="pub-id_pmid">11484904</infon><infon key="section_type">REF</infon><infon key="source">Pharmacol Toxicol</infon><infon key="type">ref</infon><infon key="volume">89</infon><infon key="year">2001</infon><offset>32554</offset><text>Role of metabolism in arsenic toxicity</text></passage><passage><infon key="fpage">41</infon><infon key="issue">1</infon><infon key="lpage">46</infon><infon key="name_0">surname:Vahter;given-names:M</infon><infon key="name_1">surname:Marafante;given-names:E</infon><infon key="pub-id_pmid">3590229</infon><infon key="section_type">REF</infon><infon key="source">Toxicol Lett</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">1987</infon><offset>32593</offset><text>Efects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit</text></passage><passage><infon key="fpage">299</infon><infon key="lpage">303</infon><infon key="name_0">surname:van Geen;given-names:A</infon><infon key="name_1">surname:Cheng;given-names:Z</infon><infon key="name_2">surname:Seddique;given-names:AA</infon><infon key="name_3">surname:Hoque;given-names:MA</infon><infon key="name_4">surname:Gelman;given-names:A</infon><infon key="name_5">surname:Graziano;given-names:JH</infon><infon key="pub-id_pmid">15667109</infon><infon key="section_type">REF</infon><infon key="source">Environ Sci Technol</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">2005</infon><offset>32708</offset><text>Reliability of a commercial kit to test groundwater for arenic in Bangladesh</text></passage><passage><infon key="fpage">377</infon><infon key="lpage">384</infon><infon key="name_0">surname:Waalkes;given-names:MP</infon><infon key="name_1">surname:Liu;given-names:J</infon><infon key="name_2">surname:Ward;given-names:JM</infon><infon key="name_3">surname:Bhalchandra;given-names:AD</infon><infon key="pub-id_pmid">15276417</infon><infon key="section_type">REF</infon><infon key="source">Toxicol Appl Pharmacol</infon><infon key="type">ref</infon><infon key="volume">198</infon><infon key="year">2004</infon><offset>32785</offset><text>Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice</text></passage><passage><infon key="fpage">295</infon><infon key="issue">3</infon><infon key="lpage">305</infon><infon key="name_0">surname:Waalkes;given-names:MP</infon><infon key="name_1">surname:Liu;given-names:J</infon><infon key="name_2">surname:Ward;given-names:JM</infon><infon key="name_3">surname:Diwan;given-names:BA</infon><infon key="pub-id_pmid">16712894</infon><infon key="section_type">REF</infon><infon key="source">Toxicol Appl Pharmacol</infon><infon key="type">ref</infon><infon key="volume">215</infon><infon key="year">2006</infon><offset>32884</offset><text>Enhanced bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethyl-stilbestrol or tamoxifen</text></passage><passage><infon key="fpage">285</infon><infon key="lpage">289</infon><infon key="name_0">surname:Wasserman;given-names:G</infon><infon key="name_1">surname:Liu;given-names:X</infon><infon key="name_2">surname:Parvez;given-names:F</infon><infon key="name_3">surname:Ahsan;given-names:H</infon><infon key="name_4">surname:Factor-Litvak;given-names:P</infon><infon key="name_5">surname:Kline;given-names:J</infon><infon key="pub-id_pmid">17384779</infon><infon key="section_type">REF</infon><infon key="source">Environ Health Perspect</infon><infon key="type">ref</infon><infon key="volume">115</infon><infon key="year">2007</infon><offset>33034</offset><text>Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh</text></passage><passage><infon key="fpage">1329</infon><infon key="lpage">1333</infon><infon key="name_0">surname:Wasserman;given-names:GA</infon><infon key="name_1">surname:Liu;given-names:X</infon><infon key="name_2">surname:Parvez;given-names:F</infon><infon key="name_3">surname:Ahsan;given-names:H</infon><infon key="name_4">surname:Factor-Litvak;given-names:P</infon><infon key="name_5">surname:van Geen;given-names:A</infon><infon key="pub-id_pmid">15345348</infon><infon key="section_type">REF</infon><infon key="source">Environ Health Perspect</infon><infon key="type">ref</infon><infon key="volume">112</infon><infon key="year">2004</infon><offset>33131</offset><text>Water arsenic exposure and childrenâs intellectual function in Araihazar, Bangladesh</text></passage><passage><infon key="fpage">29</infon><infon key="issue">1</infon><infon key="lpage">34</infon><infon key="name_0">surname:Yang;given-names:CY</infon><infon key="name_1">surname:Chang;given-names:CC</infon><infon key="name_2">surname:Tsai;given-names:SS</infon><infon key="name_3">surname:Chuang;given-names:HY</infon><infon key="name_4">surname:Ho;given-names:CK</infon><infon key="name_5">surname:Wu;given-names:TN</infon><infon key="pub-id_pmid">12550085</infon><infon key="section_type">REF</infon><infon key="source">Environ Res</infon><infon key="type">ref</infon><infon key="volume">91</infon><infon key="year">2003</infon><offset>33218</offset><text>Arsenic in drinking water and adverse pregnancy outcome in an arseniasis-endemic area in northeastern Taiwan</text></passage><passage><infon key="fpage">1259</infon><infon key="issue">11</infon><infon key="lpage">1262</infon><infon key="name_0">surname:Yu;given-names:RC</infon><infon key="name_1">surname:Hsu;given-names:KH</infon><infon key="name_2">surname:Chen;given-names:CJ</infon><infon key="name_3">surname:Froines;given-names:JR</infon><infon key="pub-id_pmid">11097236</infon><infon key="section_type">REF</infon><infon key="source">Cancer Epidemiol Biomarkers Prev</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2000</infon><offset>33327</offset><text>Arsenic methylation capacity and skin cancer</text></passage><passage><infon key="fpage">201</infon><infon key="lpage">214</infon><infon key="name_0">surname:Zheng;given-names:Y</infon><infon key="name_1">surname:Stute;given-names:M</infon><infon key="name_2">surname:van Geen;given-names:A</infon><infon key="name_3">surname:Gavrieli;given-names:I</infon><infon key="name_4">surname:Dhar;given-names:R</infon><infon key="name_5">surname:Simpson;given-names:HJ</infon><infon key="section_type">REF</infon><infon key="source">Appl Geochem</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2004</infon><offset>33372</offset><text>Redox control of arsenic mobilization in Bangladesh groundwater</text></passage><passage><infon key="file">ehp0115-001503f1.jpg</infon><infon key="id">f1-ehp0115-001503</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>33436</offset><text>Associations between cord and maternal blood arsenic for (A) total blood arsenic (n = 30, r = 0.97, Î² = 0.90, blue line; n = 101, r = 0.93, Î² = 0.94, black line) and (B) the adjusted sum of blood arsenic metabolites (DMA + MMA + As+3 + As+5) (n = 30, r = 0.99, Î² = 1.16).</text></passage><passage><infon key="file">ehp0115-001503f2.jpg</infon><infon key="id">f2-ehp0115-001503</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>33717</offset><text>Spearman correlation coefficients (r) and regression coefficients (Î²) for pairwise comparisons of cord blood arsenic metabolites and maternal blood arsenic metabolites: As+3 (r = 0.80, Î² = 0.77) (A), As+5 (r = 0.89, Î² = 0.97) (B), MMA (r = 0.81, Î² = 0.97) (C), DMA (r = 0.94, Î² = 1.06) (D) (n = 30).</text></passage><passage><infon key="file">t1-ehp0115-001503.xml</infon><infon key="id">t1-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>34032</offset><text>Characteristics of the study sample (n = 101).</text></passage><passage><infon key="file">t1-ehp0115-001503.xml</infon><infon key="id">t1-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Variable&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Value&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Range&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Motherâs age (years)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;26.0 (5.3)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;16.7â39.0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fatherâs age [years (&lt;italic&gt;n&lt;/italic&gt; = 63)]&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;34.4 (7.0)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;21.7â52.7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Motherâs education (years)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7.4 (3.6)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0â14&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fatherâs education (years)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7.6 (4.6)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0â16&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Motherâs height (cm)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;150.1 (6.0)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;134â164&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Parity&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.8 (0.90)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1â4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Gestational age (days)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;278.4 (16.6)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;218â318&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Placenta weight (g)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;513.6 (120.5)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;300â1,030&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Birth weight (g)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2752.4 (456.4)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1,160â4,000&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Birth length (cm)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;47.9 (2.9)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;32.6â54&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Head circumference [cm (&lt;italic&gt;n&lt;/italic&gt; =100)]&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;31.7 (2.5)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;24.2â48.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Male births&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;58 (57.4)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Female births&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;42 (42.6)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Married&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;101 (100)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;3&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;Fatherâs occupation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âUnemployed&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5 (5.0)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âFarmer/daily labor&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;24 (23.8)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âFactory worker/other paid job&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;22 (21.8)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âBusiness&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;21 (20.8)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âOther&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;29 (28.7)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Mother able to read and write&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;90 (89.1)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>34079</offset><text>Variable	Value	Range	 	Motherâs age (years)	26.0 (5.3)	16.7â39.0	 	Fatherâs age [years (n = 63)]	34.4 (7.0)	21.7â52.7	 	Motherâs education (years)	7.4 (3.6)	0â14	 	Fatherâs education (years)	7.6 (4.6)	0â16	 	Motherâs height (cm)	150.1 (6.0)	134â164	 	Parity	1.8 (0.90)	1â4	 	Gestational age (days)	278.4 (16.6)	218â318	 	Placenta weight (g)	513.6 (120.5)	300â1,030	 	Birth weight (g)	2752.4 (456.4)	1,160â4,000	 	Birth length (cm)	47.9 (2.9)	32.6â54	 	Head circumference [cm (n =100)]	31.7 (2.5)	24.2â48.2	 	Male births	58 (57.4)		 	Female births	42 (42.6)		 	Married	101 (100)		 	Fatherâs occupation	 	âUnemployed	5 (5.0)		 	âFarmer/daily labor	24 (23.8)		 	âFactory worker/other paid job	22 (21.8)		 	âBusiness	21 (20.8)		 	âOther	29 (28.7)		 	Mother able to read and write	90 (89.1)		 	</text></passage><passage><infon key="file">t1-ehp0115-001503.xml</infon><infon key="id">t1-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>34913</offset><text>Values are mean Â± SD or no. (%).</text></passage><passage><infon key="file">t2-ehp0115-001503.xml</infon><infon key="id">t2-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>34947</offset><text>Values for water, urine, and whole blood As and plasma folate, B12, and homocysteine measurements (n = 101).</text></passage><passage><infon key="file">t2-ehp0115-001503.xml</infon><infon key="id">t2-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Variable&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Value&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Range&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Water As [Î¼g/L (&lt;italic&gt;n&lt;/italic&gt; = 100)]&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;90.5 Â± 165.8&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.1â661.0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;3&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;Cord blood&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âAs (Î¼g/L)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;15.7 Â± 8.7&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.9â74.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âAs [Î¼g/L (&lt;italic&gt;n&lt;/italic&gt; = 30)]&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn3-ehp0115-001503&quot;&gt;a&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;23.1 Â± 11.2&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10.0â74.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âHemoglobin (g/dL)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;16.0 Â± 1.6&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10.8â19.4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âFolate [nmol/L (&lt;italic&gt;n&lt;/italic&gt; = 96)]&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;52.7 Â± 16.7&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;24.8â106.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âHomocysteine [Î¼mol/L (&lt;italic&gt;n&lt;/italic&gt; = 100)]&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.7 Â± 1.4&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.9â11.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âB&lt;sub&gt;12&lt;/sub&gt; [pmol/L (&lt;italic&gt;n&lt;/italic&gt; = 91)]&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;370.4 Â± 222.6&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;88.8â1321.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;3&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;Motherâs blood&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âAs (Î¼g/L)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11.9 Â± 8.6&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3.1â76.5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âAs [Î¼g/L (&lt;italic&gt;n&lt;/italic&gt; = 30)]&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn3-ehp0115-001503&quot;&gt;a&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20.0 Â± 12.1&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10.7â76.5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âHemoglobin (g/dL)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;12.7 Â± 1.4&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8.7â15.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âFolate [nmol/L (&lt;italic&gt;n&lt;/italic&gt; = 99)]&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20.3 Â± 9.9&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6.2â42.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âHomocysteine (Î¼mol/L)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6.4 Â± 1.5&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3.6â10.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âB&lt;sub&gt;12&lt;/sub&gt; [pmol/L (&lt;italic&gt;n&lt;/italic&gt; = 95)]&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;180.8 Â± 71.5&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;84.8â458.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âFolate &amp;lt; 6.8 (nmol/L)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (1.0)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âFolate &amp;lt; 9 (nmol/L)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10 (10.1)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âHomocysteine &amp;gt; 10.4 (Î¼mol/L)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2 (1.9)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âB&lt;sub&gt;12&lt;/sub&gt; &amp;lt; 185&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;56 (58.9)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;3&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;Motherâs urine&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âAs (Î¼g/L)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;127.6 Â± 232.9&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.0â1384.0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âCreatinine (mg/dL)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;48.6 Â± 35.3&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8.6â178.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âAs (Î¼g/g creatinine)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;271.7 Â± 489.5&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.2â3084.4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âpH (&lt;italic&gt;n&lt;/italic&gt; = 100)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.9 Â± 0.7&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.0â7&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>35056</offset><text>Variable	Value	Range	 	Water As [Î¼g/L (n = 100)]	90.5 Â± 165.8	0.1â661.0	 	Cord blood	 	âAs (Î¼g/L)	15.7 Â± 8.7	2.9â74.6	 	âAs [Î¼g/L (n = 30)]a	23.1 Â± 11.2	10.0â74.6	 	âHemoglobin (g/dL)	16.0 Â± 1.6	10.8â19.4	 	âFolate [nmol/L (n = 96)]	52.7 Â± 16.7	24.8â106.3	 	âHomocysteine [Î¼mol/L (n = 100)]	5.7 Â± 1.4	2.9â11.6	 	âB12 [pmol/L (n = 91)]	370.4 Â± 222.6	88.8â1321.1	 	Motherâs blood	 	âAs (Î¼g/L)	11.9 Â± 8.6	3.1â76.5	 	âAs [Î¼g/L (n = 30)]a	20.0 Â± 12.1	10.7â76.5	 	âHemoglobin (g/dL)	12.7 Â± 1.4	8.7â15.9	 	âFolate [nmol/L (n = 99)]	20.3 Â± 9.9	6.2â42.2	 	âHomocysteine (Î¼mol/L)	6.4 Â± 1.5	3.6â10.9	 	âB12 [pmol/L (n = 95)]	180.8 Â± 71.5	84.8â458.9	 	âFolate &lt; 6.8 (nmol/L)	1 (1.0)		 	âFolate &lt; 9 (nmol/L)	10 (10.1)		 	âHomocysteine &gt; 10.4 (Î¼mol/L)	2 (1.9)		 	âB12 &lt; 185	56 (58.9)		 	Motherâs urine	 	âAs (Î¼g/L)	127.6 Â± 232.9	5.0â1384.0	 	âCreatinine (mg/dL)	48.6 Â± 35.3	8.6â178.9	 	âAs (Î¼g/g creatinine)	271.7 Â± 489.5	5.2â3084.4	 	âpH (n = 100)	5.9 Â± 0.7	5.0â7	 	</text></passage><passage><infon key="file">t2-ehp0115-001503.xml</infon><infon key="id">t2-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>36115</offset><text>Values are mean Â± SD or no. (%).</text></passage><passage><infon key="file">t2-ehp0115-001503.xml</infon><infon key="id">t2-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>36149</offset><text>n = 30 subset is comprised of participants with total blood As &gt; 10 Î¼g/L.</text></passage><passage><infon key="file">t3-ehp0115-001503.xml</infon><infon key="id">t3-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>36224</offset><text>Maternal and newborn blood As metabolites and maternal urinary As metabolites for participants with total blood As &gt; 10 Î¼g/L (n = 30).</text></passage><passage><infon key="file">t3-ehp0115-001503.xml</infon><infon key="id">t3-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Variable&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Mean Â± SD&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Range&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td colspan=&quot;3&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;Cord blood As metabolites&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%DMA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;43.1 Â± 8.9&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;28.9â68.7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%MMA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;31.1 Â± 6.3&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;18.5â42.7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%As&lt;sup&gt;+3&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;12.8 Â± 2.7&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4.3â16.8&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%As&lt;sup&gt;+5&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;12.9 Â± 6.5&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4.2â31.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âSum of As metabolites (Î¼g/L)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;24.0 Â± 15.3&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.4â83.5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âTotal blood As (Î¼g/L)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;23.1 Â± 11.2&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10.0â74.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;3&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;Motherâs blood As metabolites&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%DMA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;43.5 Â± 8.0&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;32.7â66.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%MMA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;30.1 Â± 5.7&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;18.4â39.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%As&lt;sup&gt;+3&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;13.0 Â± 2.9&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4.5â18.0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%As&lt;sup&gt;+5&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;13.4 Â± 6.3&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.4â34.5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sum of As metabolites&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn4-ehp0115-001503&quot;&gt;a&lt;/xref&gt; (Î¼g/L)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20.9 Â± 13.1&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4.8â67.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Total blood As (Î¼g/L)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20.0 Â± 12.1&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10.9â76.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;3&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;Motherâs urine As metabolites&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%DMA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;86.6 Â± 5.5&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;74.8â97.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%MMA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7.6 Â± 4.1&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.5â17.7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%InAs&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.9 Â± 2.4&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.2â11.0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âSum of urinary As metabolites&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn4-ehp0115-001503&quot;&gt;a&lt;/xref&gt; (Î¼g/g creatinine)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;717.5 Â± 687.1&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;43.4â2934.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;âTotal urinary As (Î¼g/g creatinine)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;726.0 Â± 715.7&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;39.4â3084.2&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>36360</offset><text>Variable	Mean Â± SD	Range	 	Cord blood As metabolites	 	â%DMA	43.1 Â± 8.9	28.9â68.7	 	â%MMA	31.1 Â± 6.3	18.5â42.7	 	â%As+3	12.8 Â± 2.7	4.3â16.8	 	â%As+5	12.9 Â± 6.5	4.2â31.1	 	âSum of As metabolites (Î¼g/L)	24.0 Â± 15.3	5.4â83.5	 	âTotal blood As (Î¼g/L)	23.1 Â± 11.2	10.0â74.6	 	Motherâs blood As metabolites	 	â%DMA	43.5 Â± 8.0	32.7â66.9	 	â%MMA	30.1 Â± 5.7	18.4â39.2	 	â%As+3	13.0 Â± 2.9	4.5â18.0	 	â%As+5	13.4 Â± 6.3	2.4â34.5	 	Sum of As metabolitesa (Î¼g/L)	20.9 Â± 13.1	4.8â67.9	 	Total blood As (Î¼g/L)	20.0 Â± 12.1	10.9â76.6	 	Motherâs urine As metabolites	 	â%DMA	86.6 Â± 5.5	74.8â97.3	 	â%MMA	7.6 Â± 4.1	1.5â17.7	 	â%InAs	5.9 Â± 2.4	1.2â11.0	 	âSum of urinary As metabolitesa (Î¼g/g creatinine)	717.5 Â± 687.1	43.4â2934.6	 	âTotal urinary As (Î¼g/g creatinine)	726.0 Â± 715.7	39.4â3084.2	 	</text></passage><passage><infon key="file">t3-ehp0115-001503.xml</infon><infon key="id">t3-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>37229</offset><text>Reported sum values have been corrected for percent recovery, as described in âMethods.â Urine and blood As metabolites were measured by HPLC ICP-MS-DRC, whereas total urinary As and total blood As were measured by GFAA and ICP-MS-DRC, respectively.</text></passage><passage><infon key="file">t4-ehp0115-001503.xml</infon><infon key="id">t4-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>37483</offset><text>Estimated regression coefficients, Î² (SE) in models relating folate and homocysteine to maternal urinary As metabolites and maternal and cord blood metabolites.</text></passage><passage><infon key="file">t4-ehp0115-001503.xml</infon><infon key="id">t4-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;th colspan=&quot;2&quot; align=&quot;center&quot; rowspan=&quot;1&quot;&gt;Main predictor variable
&lt;hr/&gt;&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Outcome variable&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;log (folate)&lt;/th&gt;&lt;th align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;log (homocysteine)&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td colspan=&quot;3&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;Maternal urinary metabolites&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn5-ehp0115-001503&quot;&gt;a&lt;/xref&gt; (&lt;italic&gt;n&lt;/italic&gt; = 99)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%DMA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â0.6 (1.4)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â6.2 (2.6)&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn9-ehp0115-001503&quot;&gt;*&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%MMA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.1 (0.7)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.4 (1.3)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%InAs&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â0.1 (0.2)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.8 (0.3)&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn9-ehp0115-001503&quot;&gt;*&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;3&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;Maternal blood metabolites&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn6-ehp0115-001503&quot;&gt;b&lt;/xref&gt;,&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn7-ehp0115-001503&quot;&gt;c&lt;/xref&gt; (&lt;italic&gt;n&lt;/italic&gt; = 29)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%DMA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3.5 (3.3)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â10.9 (5.0)&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn9-ehp0115-001503&quot;&gt;*&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%MMA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.2 (2.1)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â2.1 (3.9)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%As&lt;sup&gt;+3&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â0.3 (1.2)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3.5 (1.9)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%As&lt;sup&gt;+5&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â0.6 (0.3)&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn9-ehp0115-001503&quot;&gt;*&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.3 (0.5)&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn9-ehp0115-001503&quot;&gt;*&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;3&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;Cord blood metabolites&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn6-ehp0115-001503&quot;&gt;b&lt;/xref&gt;,&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn8-ehp0115-001503&quot;&gt;d&lt;/xref&gt; (&lt;italic&gt;n&lt;/italic&gt; = 29)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%DMA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.1 (4.8)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â13.7 (6.2)&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn9-ehp0115-001503&quot;&gt;*&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%MMA&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.7 (3.7)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.6 (5.0)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%As&lt;sup&gt;+3&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.7 (1.5)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3.8 (1.9)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â%As&lt;sup&gt;+5&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â0.4 (0.4)&lt;/td&gt;&lt;td align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.3 (0.6)&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;tfn9-ehp0115-001503&quot;&gt;*&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>37647</offset><text>	Main predictor variable	 		 	Outcome variable	log (folate)	log (homocysteine)	 	Maternal urinary metabolitesa (n = 99)	 	â%DMA	â0.6 (1.4)	â6.2 (2.6)*	 	â%MMA	1.1 (0.7)	1.4 (1.3)	 	â%InAs	â0.1 (0.2)	0.8 (0.3)*	 	Maternal blood metabolitesb,c (n = 29)	 	â%DMA	3.5 (3.3)	â10.9 (5.0)*	 	â%MMA	1.2 (2.1)	â2.1 (3.9)	 	â%As+3	â0.3 (1.2)	3.5 (1.9)	 	â%As+5	â0.6 (0.3)*	1.3 (0.5)*	 	Cord blood metabolitesb,d (n = 29)	 	â%DMA	0.1 (4.8)	â13.7 (6.2)*	 	â%MMA	2.7 (3.7)	0.6 (5.0)	 	â%As+3	0.7 (1.5)	3.8 (1.9)	 	â%As+5	â0.4 (0.4)	1.3 (0.6)*	 	</text></passage><passage><infon key="file">t4-ehp0115-001503.xml</infon><infon key="id">t4-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>38219</offset><text>Model was adjusted for the control variables maternal age (years), parity, indicator for gestational age (&lt; 37 weeks vs. â¥ 37 weeks), and log (urinary creatinine).</text></passage><passage><infon key="file">t4-ehp0115-001503.xml</infon><infon key="id">t4-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>38385</offset><text>Unadjusted values were similar to adjusted values.</text></passage><passage><infon key="file">t4-ehp0115-001503.xml</infon><infon key="id">t4-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>38436</offset><text>Model was adjusted for the control variables maternal age (years) and parity.</text></passage><passage><infon key="file">t4-ehp0115-001503.xml</infon><infon key="id">t4-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>38514</offset><text>Model was adjusted for the control variable birth weight.</text></passage><passage><infon key="file">t4-ehp0115-001503.xml</infon><infon key="id">t4-ehp0115-001503</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>38572</offset><text>p &lt; 0.05.</text></passage></document></collection>
